Medical Communications

Showing 15 posts of 6402 posts found.

stephen_gough

Professor Stephen Gough joins Novo Nordisk as senior principal clinical scientist

October 2, 2015 Medical Communications, Research and Development Novo Nordisk, Professor Stephen Gough

Novo Nordisk has announced that Professor Stephen Gough, a renowned clinical and research specialist in diabetes, joined the company today …
genzyme_logo

Genzyme opts into Alnylam’s Thrombosis program

October 2, 2015 Medical Communications, Research and Development Alnylam, Genzyme, Sanofi, haemophilia

Sanofi subsidiary Genzyme has elected to opt into Alnylam’s investigational ALN-AT3 hemophilia program for development and potential future commercialisation in …
lyrica

Legal analysis: a summary of the Lyrica pregabalin case and the issue of cross-label use in Europe

October 2, 2015 Medical Communications Lyrica, Pfizer

The Warner Lambert v Actavis pregabalin cases have been before the UK Courts on no less than seven occasions since the beginning of …
generic_doctor

Survey finds GPs have negative views of pharma

October 2, 2015 Medical Communications

A survey by healthcare data and intelligence provider Binley’s has found that more than 40% of GPs have a negative …
sandoz_building

FDA accepts Sandoz submission for Amgen biosimilar

October 2, 2015 Medical Communications, Research and Development Amgen, FDA, Novartis, Sandoz, biosimilars

Sandoz, a Novartis company and a global leader in biosimilars, has announced today that the US Food and Drug Administration …
gene

Berg joins Genomics England project to sequence 100,000 genomes

October 2, 2015 Medical Communications, Research and Development Berg, Genomics england, artificial intelligence

Boston-based biopharmaceutical company Berg has announced it will join an industry collaboration with Genomics England, with the goal of sequencing …
stephen-whitehead-200

CEO Stephen Whitehead leaves ABPI

October 1, 2015 Medical Communications ABPI, Alison Clough, Stephen Whitehead

The ABPI has confirmed that CEO Stephen Whitehead has left the organisation. Speaking on behalf of the Board, John Kearney, …
karen_bernstein

Dr Karen Bernstein joins Ovid and Vitae boards

October 1, 2015 Medical Communications, Sales and Marketing Dr Karen Bernstein, Ovid Therapeutics, Vitae Pharmaceuticals

Ovid Therapeutics has announced the appointment of Karen Bernstein to the company’s Board of Directors. Dr Bernstein says: “I have …
crp_test

Quick test minimises unnecessary antibiotic prescribing

October 1, 2015 Medical Communications antibiotic resistance

New data presented at this week’s Royal College of General Practitioners (RCGP) Annual Conference reveals that in real-world general practice, …
sayana_press_and_pack

Pfizer’s self-injectable contraceptive becomes UK’s first

September 30, 2015 Medical Communications, Research and Development, Sales and Marketing Pfizer, Syayana Press

Pfizer’s injectable contraceptive, Sayana Press (medroxyprogesterone acetate), is now available to women in the UK for administration by self-injection following …

Roche says Esbriet shown to extend lives of IPF patients

September 30, 2015 Medical Communications, Research and Development, Sales and Marketing Esbriet, Roche, idiopathic pulmonary fibrosis

Roche has presented new clinical data and abstracts on Esbriet (pirfenidone) in the treatment of idiopathic pulmonary fibrosis (IPF), showing …
law

Legal analysis: compliance top of the agenda for big pharma

September 25, 2015 Medical Communications, Sales and Marketing lawyers, legal, pharma industry, reputation

Do you think big pharma suffers from a negative image, and if so, to what extent do you think this …

Synergy Vision shortlisted for Women of the Future awards

September 25, 2015 Medical Communications Synergy Vision, medical communications, medical communications agency, women, women of the future awards

Synergy Vision has been shortlisted for the Women of the Future (“WOF”) Awards, the movement recognising and nurturing young female …

Novartis’ new heart failure medicine recommended for EU approval

September 25, 2015 Medical Communications, Research and Development Entresto, Novartis, eams, heart failure

The Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Novartis’s heart failure medication Entresto …
abpi_acting_ceo_alison_clough

ABPI responds to UK medicines cost controversy

September 25, 2015 Medical Communications, Sales and Marketing ABPI, Cancer Drugs Fund, NHS

Alison Clough, acting CEO of the Association of the British Pharmaceutical Industry (ABPI), has responded to recent reports in the …
The Gateway to Local Adoption Series

Latest content